Toujeo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Insulin glargine

Indications/Uses

DM in adults, adolescents & childn from age of 6 yr.

Click to view Toujeo detailed prescribing information

Dosage/Direction for Use

SC Individualized dose. Once a day preferably at the same time every day. May inj up to 3 hr before or after the usual time of administration.

Click to view Toujeo detailed prescribing information

Contraindications

Hypersensitivity.

Click to view Toujeo detailed prescribing information

Special Precautions

Hypoglycemia &/or hyperglycemia. Patients w/ illness or major injury. Kidney or liver problems. Concomitant use w/ pioglitazone. Switching from another type, brand or manufacturer of insulin. May affect ability to drive & use tools or machine. Pregnancy & lactation. Childn <6 yr. Elderly ≥65 yr.

Click to view Toujeo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Toujeo detailed prescribing information

Adverse Reactions

Hypoglycaemia. Skin & allergic reactions at inj site; reddening, pain, itching, hives, swelling or inflammation at the inj site reaction. Lipoatrophy or lipohypertrophy when inj too often at the same place. Temporary visual impairment, Na retention, edema, retinopathy. Insulin administration may cause insulin antibodies to form.

Drug Interactions

Hypoglycemia w/ other antidiabetics, disopyramide, fluoxetine, sulfonamide antibiotics, fibrates, MAOIs, ACE inhibitors; medicines to relieve pain & lower fever eg, pentoxifylline, propoxyphene & salicylates (eg, acetylsalicylic acid); pentamidine. Hyperglycemia w/ corticosteroids (eg, cortisone), danazol, diazoxide, PIs, diuretics, glucagon, INH, somatropin, thyroid hormones; oestrogens & progestogens; clozapine, olanzapine & phenothiazine derivatives; sympathomimetics eg, epinephrine (adrenaline), salbutamol & terbutaline. Blood sugar level may rise or fall w/ β-blockers (eg, clonidine, guanethidine, reserpine) or clonidine; lithium salts; alcohol. Development of heart failure w/ pioglitazone.

Click to view Toujeo detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Toujeo detailed prescribing information

Storage

View Toujeo storage conditions for details to ensure optimal shelf-life.

Description

View Toujeo description for details of the chemical structure and excipients (inactive components).

MIMS Class

Insulin Preparations

ATC Classification

A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Toujeo soln for inj 300 u/mL

Packing/Price

1.5 mL x 5 × 1's (P5,741/pre-filled pen)

Toujeo

insulin glargine

Manufacturer:

sanofi-aventis

Distributor:

sanofi-aventis